Brief: Eurocine Vaccines Q1 Loss After Tax Widens To SEK 3.2 Mln
Nov 25 (Reuters) - Eurocine Vaccines AB EUCI.TE :
* RESULT AFTER TAX DURING Q1 AMOUNTED TO -3,2 M SEK (-1,8 M
SEK)
* REVENUES DURING Q1 AMOUNTED TO 158,000 SEK (0,0 M SEK)
Source text for Eikon: ID:nWkrc1RKfB
Further company coverage: EUCI.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate